Four is a crowd for antiretroviral regimens in HIV-1 infection

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1551, 2006-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiretroviral therapies in HIV-1 infection

By Morris-Jones S.   Moyle G.   Easterbrook P.J.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 8, 1997-08 ,pp. : 1049-1062

Informa Healthcare

Access to resources Recommend Favorite

Efavirenz-containing regimens superior in HIV-1 infection?

By  

Inpharma, Vol. 1, Iss. 1219, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS

By Anis A.H.  

PharmacoEconomics, Vol. 18, Iss. 4, 2000-10 ,pp. : 393-404

Adis International

Access to resources Recommend Favorite

Guidelines for antiretroviral use in HIV-1 infection during pregnancy

By  

Inpharma, Vol. 1, Iss. 1287, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cost-Efficacy Comparison among Three Antiretroviral Regimens in HIV-1 Infected, Treatment-Experienced Patients

By Ruof Jörg  

Clinical Drug Investigation, Vol. 27, Iss. 7, 2007-01 ,pp. : 469-479

Adis International

Access to resources Recommend Favorite